Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences Inc HAVLF


Primary Symbol: C.HAVN

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities... see more

Recent & Breaking News (CSE:HAVN)

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd.

Canada NewsWire June 7, 2022

HAVN Life to Present at Upcoming LD Micro Invitational XII

Newsfile June 6, 2022

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil

Canada NewsWire May 16, 2022

HAVN Life Secures Supply Agreement with Atman Retreats

Canada NewsWire May 11, 2022

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

Canada NewsWire May 2, 2022

HAVN Life Sciences (CSE:HAVN) launches the Brain Evolve Series

Azuka Onwuka April 13, 2022

HAVN Life Launches the Brain Evolve Series

GlobeNewswire April 13, 2022

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.

Canada NewsWire March 22, 2022

HAVN Life Sciences (CSE:HAVN) expands supply agreement for functional mushrooms

Caroline Egan  March 17, 2022

Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.

GlobeNewswire March 17, 2022

HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc.

Canada NewsWire March 15, 2022

HAVN Life Closes C$2,000,000 Private Placement with U.S. Institutional Investors

Canada NewsWire March 3, 2022

HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op

Canada NewsWire March 3, 2022

HAVN Life Announces CAD$2,000,000 Private Placement with U.S. Institutional Investors

Canada NewsWire March 1, 2022

HAVN Life To Present at Upcoming Emerging Growth Conference 26

Canada NewsWire March 1, 2022

HAVN Life Natural Health Products Now Available on Amazon.com

Canada NewsWire February 28, 2022

HAVN Life at Q1 2022 Virtual Investor Summit

Newsfile February 28, 2022

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

GlobeNewswire February 24, 2022

HAVN Life Announces Termination of Amalgamation Agreement to Acquire Spore Life Sciences

PR Newswire February 22, 2022

HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market

PR Newswire February 17, 2022